NCT06756035 2026-06-04CT-95 in Advanced Cancers Associated With Mesothelin ExpressionContext Therapeutics Inc.Phase 1 Recruiting70 enrolled
NCT06638931 2026-04-15ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Recruiting28 enrolled